The present invention is concerned with increasing protein intake in a ruminant animal by supplementing the diet of the ruminant animal with urea phosphate. There can also be supplementation with a water soluble sulfur-containing salt such as ammonium sulfate. Urea can be administered together with urea phosphate. The composition provides a slow release form of urea that avoids inducing ammonia toxicity in the animal and is water soluble for administration to the animal in drinking water.

The invention relates to a particulate urea-based composition comprising elemental sulphur and a urease inhibitor of the type phosphoric triamide, wherein the urea-based composition comprising elemental sulphur is further characterized in that it comprises a magnesium sulphate. The composition according to the invention has improved properties for reducing ammonia loss by urease activity in the soil and is in particular suitable as a fertilizer. The invention further relates to a method for the manufacture of a particulate urea-based composition comprising urea, elemental sulphur and a urease inhibitor of the type phosphoric triamide, in particular N-(n-butyl) thiophosphoric triamide (nBTPT), as well as to a composition of kit of parts comprising a magnesium sulphate.

The invention relates to a homogeneous, solid, particulate, urea ammonium sulphate (UAS)-based composition comprising urea ammonium sulphate, a urease inhibitor of the type phosphoric triamide and magnesium sulphate, characterized in that the UAS-based composition comprises 0.02 to 1 weight % of magnesium sulphate, 0.0001 to 1 weight % of the urease inhibitor and about 5 to about 30 weight % of ammonium sulphate. The composition according to the invention has improved properties for reducing ammonia loss by urease activity in the soil and is in particular suitable as a fertilizer. The invention further relates to a method for the manufacture of a homogeneous, solid, particulate urea ammonium sulphate-based composition comprising urea, ammonium sulphate and a urease inhibitor of the type phosphoric triamide, in particular N-(n-butyl) thiophosphoric triamide (nBTPT), as well as to a composition of kit of parts comprising an amount of a) magnesium sulphate; b) a urease inhibitor of the type phosphoric triamide, preferably N-(n-butyl) thiophosphoric triamide (nBTPT); c) optionally, an alkaline or alkaline-forming compound, selected from the group of calcium oxide, zinc oxide, magnesium oxide, calcium carbonate, and mixtures thereof, and d) optionally, one or more anti-caking and/or moisture-repellent and/or anti-dust compounds.

The invention relates to the use of an antibiotic-free antimicrobial feed additive in a method of improving the health of animals and/or reducing methane production of animals. The invention also provides an antimicrobial composition which is used at a low concentration, an antimicrobial composition which has a low ratio of iodide ions to hydrogen peroxide, and uses of these compositions as antimicrobial agents. The invention also provides the use of an antimicrobial composition in combination with an antibiotic as an antimicrobial agent.

The invention relates to a particulate urea-based blend composition comprising a urea-based compound in particulate form and one or more components in particulate form, selected from the group of nitrates, phosphates, sulphates and chlorides, and a urease inhibitor of the type phosphoric triamide, and a magnesium sulphate, wherein the urea-based blend composition is further characterized in that it comprises an alkaline or alkaline-forming compound, selected from the group of calcium oxide, zinc oxide, magnesium oxide, calcium carbonate, and mixtures thereof. The composition according to the invention has improved properties for reducing ammonia loss by urease activity in the soil and is in particular suitable as a fertilizer. The invention further relates to a method for the manufacture of said urea-based blend composition, as well as to a composition of kit of parts comprising an amount of a) magnesium sulphate; b) a urease inhibitor of the type phosphoric triamide, preferably N-(n-butyl) thiophosphoric triamide (nBTPT); c) an alkaline or alkaline-forming compound, selected from the group of calcium oxide, zinc oxide, magnesium oxide, calcium carbonate, and mixtures thereof, and d) optionally, one or more anti-caking and/or moisture-repellent and/or anti-dust compounds.

A system according to various embodiments can include a source for supplying a material to be treated, an extruder, at least two screws, and a drive coupled to the screws for axially rotating the screws. The extruder includes an inlet for receiving the material, which is fed therein in a controlled manner. The screws are provided within the housing of the extruder. The screws have a plurality of compression and release stages that create mechanical heat which is directly applied to the material to change the mechanical properties of the material thereby facilitating a conversion of a physical state of the material from a non-compactable state to a compactable state as the screws rotate and move the material longitudinally along the screws to produce a final product, for example, a feed tub for use as an animal feed.

A 25-hydroxycholecalciferol monohydrate crystal, a preparation method thereof, and a microemulsion using the 25-hydroxycholecalciferol monohydrate crystal. The X-ray powder diffraction spectrum of the 25-hydroxycholecalciferol monohydrate crystal of the present disclosure shows characteristic peaks at 2 of 10.035, 11.623, 14.631, 15.054, 15.551, 16.471, 17.198, 19.002, 19.628, 20.109, 21.886, 23.113, 23.661, 24.701, 25.220, 25.440, and 28.527. The 25-hydroxycholecalciferol monohydrate crystal can effectively enhance the stability of 25-hydroxycholecalciferol, and is more beneficial to the production and storage of related preparations, and thus biological characteristics of 25-hydroxycholecalciferol can be effectively utilized.

Chemically modified methionine hydroxy analogs that are protected from degradation by rumen microorganisms. The chemically modified compounds comprise methionine hydroxy analog chemically linked to a fatty acid having at least 12 carbon atoms. Methods for increasing rumen bypass of methionine hydroxy analog and/or providing methionine hydroxy analog to a ruminant's small intestine for absorption, wherein the methods comprise administering to the ruminant a chemically modified methionine hydroxy analog as defined above.

Chemically modified methionine hydroxy analogs that are protected from degradation by rumen microorganisms. The chemically modified compounds comprise methionine hydroxy analog chemically linked to a fatty acid having at least 12 carbon atoms. Methods for increasing rumen bypass of methionine hydroxy analog and/or providing methionine hydroxy analog to a ruminant's small intestine for absorption, wherein the methods comprise administering to the ruminant a chemically modified methionine hydroxy analog as defined above.

A process of encapsulating or coating amino acid particles is provided for producing an encapsulated amino acid feed product for ruminant animals. The encapsulated amino acid feed product comprises substantially uniform, round and dust free pastille granules. When the encapsulated amino acid feed product is fed to a ruminant animal, the product delivers high amounts of absorbable amino acid to the animal for direct nourishment, wherein the amino acid is not substantially fermented in the rumen of the animal. In an aspect, the process is a low-cost, high capacity, continuous process that produces a composition comprising greater than 50% by weight of a nourishing amino acid. The superior handling quality of the pastille granules allows for their use in further formulation of animal feeds, where homogeneous distribution of nutrients throughout the final feed mix is desired.